Figure 5 | British Journal of Cancer

Figure 5

From: A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT

Figure 5

TGFβ1 treatment has differential effects on EMT in A549 cells compared with ectopic mir-200c expression. (AC) A549 or A549+mir200c cells were treated for 3 days with TGFβ1 (2 ng ml−1). (A) Cellular morphology is altered in the presence TGFβ1 in both cell lines. (B) Proteins involved in EMT are differentially expressed in the presence of TGFβ1 in A549 and A549+mir200c-expressing cells. ZEB1, E-cadherin, β-catenin, Snail, and pERK1/2 expression was determined by western analysis. α-Tubulin serves as a loading control. (C) Expression of EMT effector mRNA and a panel of signature miRNAs are differentially expressed in A549 and A549+mir200c expressing. Expression of ZEB1, E-cadherin, mir-200c, mir-34c, mir-301a, and mir-140 genes were evaluated by qPCR in control and mir-200c-expressing cells. The data are mean fold change, relative to control (untreated A549 cells), of two independent experiments each evaluated in triplicate. Bars show standard deviation (s.d.).

Back to article page